Log in
Enquire now

List of Genocea Biosciences patents

List of Genocea Biosciences patents
List of Merck patents
List of Celcuity patents
List of Myriad Women's Health, Inc. patents
List of NGOs in Ypsilanti, Michigan
List of Integrated Diagnostics patents
Patents where
Current Assignee
Name
is
Genocea BiosciencesGenocea Biosciences
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9624273 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent 9624273 was granted and assigned to Genocea Biosciences on April, 2017 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9624273
April 18, 2017
‌
US Patent 9045791 Antigen screening system

Patent 9045791 was granted and assigned to Genocea Biosciences on June, 2015 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9045791
June 2, 2015
‌
US Patent 9873870 Antigen screening system

Patent 9873870 was granted and assigned to Genocea Biosciences on January, 2018 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9873870
January 23, 2018
‌
US Patent 11162093 Antigen screening system

Patent 11162093 was granted and assigned to Genocea Biosciences on November, 2021 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11162093
November 2, 2021
‌
US Patent 10350288 Methods and compositions for treating herpes

Patent 10350288 was granted and assigned to Genocea Biosciences on July, 2019 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10350288
July 16, 2019
‌
US Patent 10653771 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent 10653771 was granted and assigned to Genocea Biosciences on May, 2020 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10653771
May 19, 2020
‌
US Patent 9895436 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent 9895436 was granted and assigned to Genocea Biosciences on February, 2018 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9895436
February 20, 2018
‌
US Patent 10859566 Treatment methods

Patent 10859566 was granted and assigned to Genocea Biosciences on December, 2020 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10859566
December 8, 2020
‌
US Patent 10570387 Antigen screening system

Patent 10570387 was granted and assigned to Genocea Biosciences on February, 2020 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10570387
February 25, 2020
‌
US Patent 9782474 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent 9782474 was granted and assigned to Genocea Biosciences on October, 2017 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9782474
October 10, 2017
‌
US Patent 8617564 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Patent 8617564 was granted and assigned to Genocea Biosciences on December, 2013 by the United States Patent and Trademark Office.

Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8617564
December 31, 2013
‌
US Patent 8313894 Antigen screening system

Genocea Biosciences
Genocea Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8313894
November 20, 2012
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us